(Q71102237)
Statements
Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma (English)
Bal C
Padhy AK
Jana S
Pant GS
scientific article published on 01 June 1996